CAV2 and idiopathic pulmonary fibrosis: Furthermore, it inhibited the proliferation of lung fibroblasts through miR-203/Cav2, thereby preventing the excessive deposition of ECM and reducing idiopathic pulmonary fibrosis (IPF) [53].